Glucorell, Anafit settle FTC deceptive advertising claims
WASHINGTON Two marketers of dietary supplements that purportedly prevented and treated diabetes have settled Federal Trade Commission charges that they engaged in deceptive advertising practices, FTC reported Thursday.
According to the FTC’s complaint, GlucorelFTCd and Anafit, both based in Orlando, Fla., made false and unsubstantiated claims that two dietary supplements, Insulow and Glucorell R, were effective for preventing and treating diabetes.
The order contains a judgment of $493,545, which is the total amount the defendants received in sales for Glucorell R and Insulow between January 2005 and May 2008. However, the entire judgment is suspended due to their inability to pay. If it is determined that the financial information given to the FTC was untruthful, then the full amount of the judgment will automatically become due.
Along with statements in their ads such as “Insulow may be the only thing between you … and a needle,” the defendants also made unsubstantiated claims that Insulow prevents or reduces the risk of developing Type 2 diabetes, is an effective treatment for Type 1 and Type 2 diabetes, lowers high blood sugar levels, prevents or reverses insulin resistence, increases fat loss and decreases insulin-related obesity and enables diabetics to reduce or eliminate the amount of drugs and insulin required to keep blood sugar levels healthy and reduce insulin resistance, according to the complaint. The FTC also alleged that the defendants falsely advertised that all of these claims except the last had been proven by clinical studies.
For Glucorell R, the defendants’ advertisements allegedly claimed that Glucorell R is effective for treating Type 2 diabetes, prevents or reduces the risk of developing Type 2 diabetes and is effective in treating and preventing cancer. According to the complaint, the defendants also falsely advertised that the last two Glucorell R claims were proven by clinical studies.
According to papers filed with the court, Glucorell has been primarily responsible for packaging, distributing and selling Insulow, and has marketed both supplements; while Anafit has been responsible for packaging, distributing, selling and marketing only Glucorell R.
HDI posts positive 3Q gains; launches two glucose meters
FORT LAUDERDALE, Fla. Home Diagnostics on Thursday posted revenue of $35.6 million for the three months ending Sept. 30, realizing an increase of 12.2 percent as compared to the year-ago quarter. And retail channel sales were up 38.5 percent, Home Diagnostics reported, driven by the initial launch of the new TRUE2go and TRUEresult blood glucose monitoring systems with Walgreens and strong sales of the TRUEtrack product with existing customers.
“During the third quarter we realized the benefits of several key elements of our growth strategy,” J. Richard Damron, Home Diagnostics’ president and chief executive officer said. “Most importantly, we received FDA clearance for our new no-coding TRUE2go and TRUEresult systems in mid-August, positioning Home Diagnostics into the premium segment of the market. We are pleased with the product’s initial sales trends and are continuing to ship products to our co-brand partners.”
Along with its latest quarterly results, Home Diagnostics announced that it plans to significantly expand its test strip manufacturing capacity to meet the expected demand of its new TRUEresult and TRUE2go systems.
Lansinoh launches online tool, social networking for new moms
ALEXANDRIA, Va. Lansinoh Laboratories on Wednesday launched its new online community—Lansinohmoms.com—to help connect mothers nationwide.
“Lansinoh has been supporting and nurturing a community of new mothers for more than 20 years, so creating a place where moms can virtually find and share answers, encouragement and support from other moms online is a natural extension,” Kira Wood, director of marketing at Lansinoh, said.
New members to the www.Lansinohmoms.com community will be given the opportunity to create a personal profile, so their new online friends can get to know them and their motherhood experiences. Lansinoh plans to poll those moms on various topics, with the results shared so the members can see how other moms are thinking and feeling.
“Lansinoh was started by a breastfeeding mother who developed a product, Lansinoh Lanolin, that helped solve a problem she was experiencing—sore, cracked nipples—but for which no product existed at the time,” Wood said. “That unique product become a springboard for a whole category of products for breastfeeding women and now, after more than two decades of talking to new moms through Lansinoh’s breastfeeding outreach efforts, we understand that women crave information and love to share their own knowledge and experiences with other moms in similar situations.”
Lansinohmoms.com will also soon feature online guests, including lactation consultants and other breastfeeding experts to take part in discussions about different pressing topics.
“The Lansinoh Community forum will allow moms to candidly discuss their experiences as a mother, share tips with other members and even ask our experts questions related to motherhood,” Wood said.
“With all the new challenges and decisions mothers are faced with each day, we hope this forum will be a meaningful and refreshing pause in their day,” Wood added. “We are really excited about this site and are determined to make this a place where moms will feel confident that they will get the support they need, in addition to the accurate and helpful information they want and deserve.”